Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now located in Boston'sInnovation District. Today, the company has research and development sites and commercial offices in the United States, Europe, Canada, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including being named to Science magazine's Top Employers in the life sciences ranking for nine years in a row. *

 

Period Start 1998-02-21 existent
Period End 1998-02-21 existent
  Group Vertex Pharmaceuticals (Group)
Product Industry pharmaceutical
Person Person Leiden, Jeffrey M. (Vertex 20212– CEO before Clarus Ventures + Abbott)
     
Region Region Boston, MA
  Country United States (USA)
  Street 50 Northern Avenue
  City 02210 Boston, MA
  Tel +1-617-444-6100
    Address record changed: 2019-06-13
     
Basic data Employees n. a.
  Currency USD
  Annual sales 199,012,000 (revenues, total, consolidated (2007) 2007-12-31)
  Profit -391,279,000 (2007-12-31)
  Cash 467,796,000 (2007-09-30)
     
    * Document for �About Section�: Vertex Pharmaceuticals Inc.. (6/6/19). "Press Release: Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics". Boston, MA & Watertown,
     
   
Record changed: 2019-11-21

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Vertex Pharmaceuticals (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top